ORC1 missense mutations were present in the TCGA PanCancer Atlas with a variable frequency (between 0.2 and 5.5%), the tumour types with the highest frequencies were endometrial cancers and cutaneous melanoma (Supplementary Fig. 8a). This evidence concerns the gene ORC1 and endometrial cancer.